Recovery Peptides

Body Protection Compound-157

BPC-157 is the most widely studied recovery peptide in the research peptide market, with published work spanning tendon and ligament repair, gut lining integrity, wound healing, and modulation of inflammatory cytokines including CRP, IL-6, and TNF-alpha. It is typically run subcutaneously in 4–8 week cycles at 200–500mcg twice daily, often stacked with TB-500 for orthopedic recovery research. Chad’s platform tracks CRP and IL-6 as the primary response markers and monitors liver enzymes for safety.

Thymosin Beta-4

TB-500 is the synthetic fraction of thymosin beta-4, a naturally occurring regulatory peptide present in virtually every human cell. Research has focused on its role in cell migration, angiogenesis, and the reduction of pro-inflammatory cytokines — making it a common study partner for BPC-157 in tissue repair protocols. Typical research dosing is 2–5mg twice weekly in 4–8 week cycles. Because of its longer half-life, researchers monitor CRP, ESR, WBC, and ferritin to track inflammatory response and catch any early signs of iron dysregulation.

Elamipretide

SS-31 (elamipretide) is a mitochondria-targeted tetrapeptide that concentrates in the inner mitochondrial membrane to improve energy production and reduce oxidative stress. It is in clinical trials for mitochondrial myopathy, heart failure, and age-related mitochondrial dysfunction.

Oral BPC-157

Oral BPC-157 is a stabilized oral formulation of the pentadecapeptide Body Protection Compound-157, designed to survive gastric degradation and deliver systemic healing effects via oral administration. Various salt forms (arginate, acetate) aim to improve oral bioavailability.

Cibinetide

ARA-290 (Cibinetide) is a synthetic 11-amino-acid peptide derived from erythropoietin (EPO) that selectively activates the innate repair receptor (IRR) for neuroprotective and tissue repair properties without erythropoietic effects.

Ala-Glu-Asp-Arg

Cardiogen is a synthetic tetrapeptide (Ala-Glu-Asp-Arg) from the Khavinson bioregulator series, studied for potential regulatory effects on cardiovascular tissue gene expression and cardiomyocyte function in preclinical models.

Ala-Glu-Asp

Cartalax is a synthetic tripeptide (Ala-Glu-Asp) from the Khavinson bioregulator series, studied for potential effects on cartilage tissue maintenance, chondrocyte function, and musculoskeletal aging.

Wolverine Blend

Pre-mixed blend of BPC-157 and TB-500 in a single vial. The most popular peptide combination in the research market, combining gastric pentadecapeptide repair signaling with thymosin beta-4 cell migration.

GLOW

Pre-mixed triple blend of GHK-Cu, BPC-157, and TB-500. Combines copper-peptide matrix remodeling with the Wolverine stack's repair pathways for a comprehensive tissue recovery formulation.

KLOW

Pre-mixed quad blend adding KPV (anti-inflammatory alpha-MSH fragment) to the GLOW stack. Extends the tissue repair formulation with NF-kB-mediated inflammation suppression.